Purchase Order 75N90025P00766
Award Date 9/26/25
Potential Completion Date 9/25/26
Potential Value $23K
Federal Agency
Ultimate Awardee
NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
San Jose, CA 95131, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the National Institutes of Health (NIH) Clinical Center to Becton, Dickinson & Co (BD), a global medical technology company. The $23,686.25 firm fixed-price purchase order is for the supply of Rhapsody Targeted mRNA AbSeq Kits and AB-O Single Cell Sample Multiplexing Kits. The contract has a period of performance through July 19, 2025 and was awarded on a full and open competition basis without any set-aside designation. BD is an established...
- This is a firm-fixed-price purchase order contract awarded by the National Institutes of Health (NIH) Clinical Center to Becton, Dickinson and Company (BD) for the supply of D RHAPSODY SINGLE-CELL ANALYSIS REAGENT KITS. The contract has a ceiling value of $16,130.00 and a completion date of October 9, 2025. The contract is not designated as a set-aside. BD is a global medical technology company that provides a range of medical devices, diagnostic products, and laboratory equipment to federal...
- Becton, Dickinson and Company (BD) has been awarded a firm fixed price purchase order by the Department of Health and Human Services' National Institutes of Health Clinical Center. Valued at eleven thousand six hundred seventy-one dollars and sixty cents ($11,671.60), this award is for the RHAPSODY Targeted mRNA ABSEQ Kit. Delivery is required by February 23, 2024. As a manufacturer and supplier of medical devices, instruments, reagents, and related products, BD will provide the requested...
- The Department of Health and Human Services National Institutes of Health Clinical Center awarded a Firm Fixed Price purchase order to Becton, Dickinson and Company (BD), a manufacturer of medical devices, instruments, and reagents. The $38,920.00 contract is for BD reagents to be used for single-cell abseq analysis on BD Rhapsody instruments in the PACT section of the Clinical Center. The contract has an August 30, 2024 completion date and was awarded on May 15, 2024. This purchase order is not...
- This federal contract award was issued by the National Institutes of Health (NIH) Clinical Center to Becton, Dickinson and Company (BD), a global medical technology manufacturer. The $14,293.20 firm fixed price contract is a Blanket Purchase Agreement (BPA) call for the delivery of flow cytometry instruments, maintenance services, and related consumables. The contract has no set-aside designation, indicating BD's competitive position as a large, established provider of medical research equipment...
- This federal contract award is for the procurement of specialized medical diagnostic equipment and related supplies from Becton, Dickinson and Company (BD), a global medical technology company. The $13,845.00 firm fixed-price purchase order was awarded by the National Institutes of Health (NIH) Clinical Center, a civilian federal agency. The contract covers the delivery of BD Biosciences-Clontech products, which are likely flow cytometry instruments, reagents, and other laboratory equipment used...
- This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Becton, Dickinson and Company (BD) for $33,675.60. The contract is for BD Biosciences, a division of BD, to provide biomedical instruments, reagents, and services that support flow cytometry, cell imaging, and genomics technologies. BD has extensive experience providing specialized equipment and consumables to support...
- This is a $39,000 firm-fixed-price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Becton, Dickinson and Company (BD) to provide proprietary reagent kits for flow cytometry applications. The contract has an ultimate completion date of September 30, 2024. BD Biosciences, a division of BD, is the vendor providing these specialized reagents to support biomedical research and clinical programs at the NIH. The contract is not designated as a set-aside. BD has...
- This federal contract award to Becton, Dickinson and Company (BD), a global medical technology company, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH). The contract is a Blanket Purchase Agreement (BPA) call order for the supply of HU CD3 NHP APC-CY7 flow cytometry reagents, with a ceiling value of $16,501.20. The fixed-price contract has a period of performance ending on March 31, 2012. BD, through its BD...
- This firm-fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Becton, Dickinson and Company (BD) for $24,138.00. The contract is for the delivery of unspecified products or services related to BD's Biosciences division, which provides instruments, reagents, and services that support biomedical research and clinical applications through flow cytometry, cell imaging, and genomics...